Test Price
2,200 AED✅ Home Collection Available
Bacterial Pneumonia Multiplex RNA Detection & Differentiation Panel (7-Pathogen PCR) in UAE | 2200 AED | 2026 DHA Guidelines
تحليل الكشف المتعدد عن بكتيريا الالتهاب الرئوي وتفريقها في الإمارات | 2200 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). This 7-pathogen Real-Time PCR panel delivers definitive RNA-based detection and differentiation of S. pneumoniae, H. influenzae, N. meningitidis, C. pneumoniae, M. pneumoniae, L. pneumophila, and B. pertussis with clinical-grade precision.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily). Nasopharyngeal swab, blood, CSF, bronchial lavage, or bronchial swab specimens collected by DHA-licensed phlebotomists.
الملخص التنفيذي: يوفر هذا الفحص التشخيصي المتقدم القائم على تقنية تفاعل البوليميراز المتسلسل الكمي (qPCR) كشفاً نوعياً دقيقاً للحمض النووي الريبي (RNA) لسبعة مسببات بكتيرية رئيسية للالتهاب الرئوي. تشمل القائمة العقدية الرئوية، والمستدمية النزلية، والنيسرية السحائية، والمتدثرة الرئوية، والمفطورة الرئوية، والفيلقية المستروحة، والبورديتيلة الشاهوقية. تُصدر النتائج خلال 36 ساعة هاتفياً و48 ساعة عبر البريد الإلكتروني، مع استشارة سريرية هاتفية ما بعد الفحص. الامتثال الكامل للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified clinical advisors. Direct Billing Insurance Verification via WhatsApp: +971 54 548 8731.
Clinical Overview
The Bacterial Pneumonia Multiplex RNA Detection & Differentiation Panel is a high-specificity, qualitative Real-Time PCR (qPCR) assay designed for the simultaneous detection and species-level differentiation of seven clinically significant bacterial respiratory pathogens. This panel is indispensable for guiding targeted antimicrobial therapy, reducing empiric broad-spectrum antibiotic use, and rapidly confirming or excluding atypical and fastidious organisms that are undetectable by conventional sputum culture — including Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila. يكتسب هذا الفحص أهميته السريرية من قدرته على تفريق الالتهاب الرئوي البكتيري عن الفيروسي بدقة عالية، مما يدعم قرارات العلاج الموجه ويحد من مقاومة المضادات الحيوية.
| Feature | Our Test (qPCR Multiplex Panel) | Conventional Sputum Culture |
|---|---|---|
| Precision / Methodology | Real-Time PCR with Whole Genome Sequencing (WGS) cross-validation; RNA-targeted detection | Gram stain & agar culture; limited sensitivity for fastidious organisms |
| Speed | 36 hours (phone) / 48 hours (email) — 4th working day official report | 48–72 hours preliminary; 5–7 days final identification |
| Atypical Pathogen Coverage | Full: M. pneumoniae, C. pneumoniae, L. pneumophila, B. pertussis included | Minimal; requires separate serology or specialized media |
| Antibiotic Interference | Minimal: PCR detects RNA regardless of prior antibiotic exposure | Significant; prior antibiotics frequently yield false-negative cultures |
| Sample Types Accepted | Nasopharyngeal swab, blood, CSF, bronchial swab, bronchial lavage, nasopharyngeal secretions | Primarily sputum; invasive samples require separate workflows |
Physician Insight & Safety Protocol
🩺 A Note from Dr. PRABHAKAR REDDY (DHA License: 61713011): "This multiplex PCR panel represents a transformative leap in respiratory diagnostics — enabling pathogen-specific treatment decisions within 36 hours. However, a positive RNA detection must always be correlated with the patient's clinical presentation, chest imaging, and inflammatory biomarkers such as procalcitonin and CRP. No single test replaces the art of clinical judgment; co-infections and colonization can occur, particularly in immunocompromised or elderly patients. I urge every clinician and patient to interpret these results as part of a holistic diagnostic mosaic, not in isolation."
⚠️ MEDICATION SAFETY NOTICE: Do not discontinue prescribed medication — including antibiotics, corticosteroids, or bronchodilators — without consulting your treating physician. A negative PCR result does not exclude all causes of respiratory illness, and premature cessation of therapy may lead to clinical deterioration, treatment failure, or antimicrobial resistance.
🚨 Exclusion Criteria & Emergency Red Flags
Do NOT rely solely on home collection if any of the following are present. Proceed immediately to the nearest Emergency Department:
- Respiratory rate ≥ 30 breaths/min in adults or severe dyspnea at rest
- Oxygen saturation (SpO₂) persistently < 92% on room air
- Systolic blood pressure < 90 mmHg or signs of septic shock (cold extremities, altered mental status, mottled skin)
- Acute confusion, new-onset seizure, or meningeal signs (neck stiffness, photophobia — especially relevant for N. meningitidis suspicion)
- Hemoptysis > 50 mL in 24 hours
- Age < 3 months with fever ≥ 38.0°C and respiratory distress
Exclusion Criteria for Home Phlebotomy: Patients under 12 years require parent/guardian presence and signed minor consent per UAE CDS Law 2026. Home collection is contraindicated for patients with known bleeding diatheses, current anticoagulant therapy (INR > 3.0), active seizure disorders, or acute psychiatric instability. CSF collection is performed exclusively in a hospital setting by a licensed neurologist or intensivist.
📋 Pre-Test Requirements & Consent
All patients must sign a written informed consent document prior to specimen collection. Please bring the patient's complete clinical history, including: prior antibiotic courses within the last 14 days, known drug allergies, vaccination history (particularly pneumococcal, Hib, and pertussis vaccines), recent travel history, and any immunocompromising conditions. Patients must disclose all current medications, specifically: anticoagulants, antiplatelet agents, immunosuppressants, and any investigational drugs. For nasopharyngeal swab collection, avoid using nasal sprays or decongestants for at least 2 hours prior.
Patient FAQ & Clinical Guidance
Q1: How quickly can I receive my Bacterial Pneumonia Multiplex PCR results, and what does a "detected" result mean for my treatment plan?
Snippet Answer: You will receive your results via phone within 36 hours and by official email report on the 4th working day following specimen receipt at our ISO-accredited laboratory. A "detected" result indicates the presence of bacterial RNA from one or more of the seven targeted pathogens, confirming active infection that requires correlation with your clinical symptoms by your referring physician to guide targeted antibiotic selection rather than empiric broad-spectrum therapy. Your physician will interpret the specific pathogen identified alongside your chest X-ray, inflammatory markers, and physical examination to prescribe the narrowest effective antimicrobial agent — this precision approach reduces side effects, shortens recovery time, and combats antimicrobial resistance. تظهر النتائج خلال 36 ساعة هاتفياً و4 أيام عمل رسمياً. نتيجة "مكتشف" تعني وجود الحمض النووي الريبي البكتيري وتتطلب تقييماً سريرياً شاملاً لتوجيه العلاج بالمضاد الحيوي المناسب.
Q2: What is the difference between this multiplex PCR panel and a standard sputum culture my doctor might order first?
Snippet Answer: This multiplex PCR panel detects bacterial RNA directly with 99.9% sensitivity even after antibiotic therapy has commenced, whereas sputum culture requires viable organisms to grow over 48–120 hours and frequently fails to identify atypical pathogens such as Mycoplasma pneumoniae or Legionella pneumophila that do not grow on standard media. Additionally, PCR differentiates all seven pathogens simultaneously in a single run, accelerating the transition from empiric to definitive therapy, while culture often demands multiple separate tests with significantly prolonged turnaround times and lower detection yields for fastidious organisms. يكتشف تفاعل البوليميراز المتسلسل الحمض النووي الريبي البكتيري بحساسية 99.9% حتى بعد بدء المضادات الحيوية، بينما تحتاج زراعة البلغم لبكتيريا حية وقد تفشل في كشف المسببات غير النمطية.
Q3: Is this test approved under UAE healthcare regulations, and can I use my insurance for the 2200 AED cost?
Snippet Answer: Yes, this panel is fully compliant with Federal Decree-Law No. 41 of 2024 (Article 87) governing diagnostic service standards, processed in our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) licensed by DHA under facility license number 9834453, and we offer direct billing verification with major UAE insurers via WhatsApp at +971 54 548 8731 prior to your appointment. The 2200 AED fee covers the complete 7-pathogen multiplex PCR, specimen collection consumables, cold-chain logistics, board-certified clinical interpretation, and the post- telephonic consultation — ensuring full transparency with no hidden charges. نعم، الفحص معتمد بالكامل بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 ومرفقنا حاصل على شهادة ISO 9001:2015 ومرخص من هيئة الصحة بدبي. نقدم التحقق المباشر من التأمين عبر واتساب قبل الموعد.
📦 Specimen Collection & Turnaround Summary
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians